In addition, OLFM4 has been reported inhibitory to the growth and metastasis of prostate cancer 19 and malignant melanoma 20, suggesting that the behaviour of OLFM4 is tissue specific or cancer type specific. This evidence concerns the gene OLFM4 and prostate carcinoma.